Your session is about to expire
← Back to Search
Non-invasive Brain Mapping for Parkinson's Disease
Study Summary
This trial is testing whether different types of movement cues can help people with Parkinson's disease move more normally, and whether brain mapping techniques can help understand how this works.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a score lower than 19 on a test that checks for memory and thinking skills.I am currently experiencing hallucinations or psychosis.I am older than 18 years.I am a healthy adult without any brain or nerve diseases.I have Parkinson's with at least 2 main symptoms or I am healthy with no brain disorders.I have Parkinson's disease with symptoms like shaking, stiffness, or slow movement.
- Group 1: Parkinson disease patients
- Group 2: Healthy adults
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals can take part in this trial at its peak?
"Affirmative. According to the clinicaltrials.gov data, this medical experiment is still recruiting individuals and was originally posted on July 6th 2022. The study necessitates 90 participants from 1 location and has been updated most recently on November 8th 2022."
Is recruitment currently underway for this medical trial?
"Affirmative. Clinicaltrials.gov documents demonstrate that this study, which became available on July 6th 2022, is currently enrolling participants. 90 individuals need to be enlisted from 1 medical site."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Most responsive sites:
- University of California Los Angeles: < 48 hours
Average response time
- < 2 Days
Typically responds via
Share this study with friends
Copy Link
Messenger